Association between the sarcopenia index and the risk of stroke in elderly patients with hypertension: a cohort study
暂无分享,去创建一个
Nan-fang Li | Yujie Dang | Jing Hong | Wenbo Yang | Q. Luo | Junli Hu | Xintian Cai | Mengru Wang | Wen Wen | Jingyu Wang | Jing Hong | Jingyu Wang | Nanfang Li | Qin Luo | Wen Wen | Xintian Cai | Junli Hu | Mengru Wang | Yujie Dang
[1] Shasha Liu,et al. Association between the geriatric nutritional risk index and the risk of stroke in elderly patients with hypertension: A longitudinal and cohort study , 2022, Frontiers in Nutrition.
[2] H. Park,et al. Serum creatinine to cystatin C ratio and clinical outcomes in adults with non-dialysis chronic kidney disease , 2022, Frontiers in Nutrition.
[3] Chenyu Sun,et al. Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours , 2022, Frontiers in Nutrition.
[4] Feng Yan,et al. Prevalence of stroke in China, 2013–2019: A population-based study , 2022, The Lancet regional health. Western Pacific.
[5] M. Fukui,et al. Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes , 2022, BMJ Open Diabetes Research & Care.
[6] Jiao-Jiao Bai,et al. Current state of care for the elderly in China in the context of an aging population. , 2022, Bioscience trends.
[7] Tianjiao Tang,et al. Serum creatinine and cystatin C‐based diagnostic indices for sarcopenia in advanced non‐small cell lung cancer , 2022, Journal of cachexia, sarcopenia and muscle.
[8] T. Oguri,et al. Serum creatinine/cystatin C ratio is a surrogate marker for sarcopenia in patients with idiopathic pulmonary fibrosis , 2022, BMC Pulmonary Medicine.
[9] J. Shin. Low serum creatinine to cystatin C ratio is independently associated with sarcopenia and high carotid plaque score in patients with type 2 diabetes. , 2022, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[10] L. Cao,et al. Association between sarcopenia and cardiovascular disease among middle-aged and older adults: Findings from the China health and retirement longitudinal study , 2022, EClinicalMedicine.
[11] J. Yue,et al. Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta‐analysis , 2022, Journal of cachexia, sarcopenia and muscle.
[12] M. Naghavi,et al. Temporal trend and attributable risk factors of stroke burden in China, 1990–2019: an analysis for the Global Burden of Disease Study 2019 , 2021, The Lancet. Public health.
[13] W. Tu,et al. Aging tsunami coming: the main finding from China’s seventh national population census , 2021, Aging Clinical and Experimental Research.
[14] K. Silay,et al. Malnutrition-sarcopenia syndrome and all-cause mortality in hospitalized older people. , 2021, Clinical nutrition.
[15] Xiping Xu,et al. Plasma selenium and the risk of first stroke in adults with hypertension: a secondary analysis of the China Stroke Primary Prevention Trial. , 2021, The American journal of clinical nutrition.
[16] Jiumei Cao,et al. Sarcopenia predicts adverse outcomes in an elderly population with coronary artery disease: a systematic review and meta-analysis , 2021, BMC Geriatrics.
[17] D. Koya,et al. Autophagy in metabolic disease and ageing , 2021, Nature Reviews Endocrinology.
[18] H. Liou,et al. Serum indices based on creatinine and cystatin C predict mortality in patients with non-dialysis chronic kidney disease , 2021, Scientific Reports.
[19] C. Agatiello,et al. Sarcopenia index as a predictor of clinical outcomes in older patients undergoing transcatheter aortic valve replacement , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[20] P. Chau,et al. The Prevalence of Sarcopenia in Chinese Older Adults: Meta-Analysis and Meta-Regression , 2021, Nutrients.
[21] Shing‐Jong Lin,et al. Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[22] Y. Fujiwara,et al. Sarcopenia: prevalence, associated factors, and the risk of mortality and disability in Japanese older adults , 2020, Journal of cachexia, sarcopenia and muscle.
[23] S. Simpson,et al. Branched chain amino acids, aging and age-related health , 2020, Ageing Research Reviews.
[24] Shiying Yu,et al. A new index based on serum creatinine and cystatin C is useful for assessing sarcopenia in patients with advanced cancer. , 2020, Nutrition.
[25] Hak Seung Lee,et al. Sarcopenia Index as a Predictor of Clinical Outcomes in Older Patients with Coronary Artery Disease , 2020, Journal of clinical medicine.
[26] M. Pizzimenti,et al. Sarcopenia and peripheral arterial disease: a systematic review , 2020, Journal of cachexia, sarcopenia and muscle.
[27] F. Goldwasser,et al. Creatinine-to-cystatin C ratio and bioelectrical impedance analysis for the assessement of low lean body mass in cancer patients: Comparison to L3-computed tomography scan. , 2020, Nutrition.
[28] Xin Gao,et al. Sarcopenia, sarcopenic overweight/obesity and risk of cardiovascular disease and cardiac arrhythmia: A cross-sectional study. , 2020, Clinical nutrition.
[29] B. Pedersen,et al. Muscle–Organ Crosstalk: The Emerging Roles of Myokines , 2020, Endocrine reviews.
[30] S. M. Barbalho,et al. Physical Exercise and Myokines: Relationships with Sarcopenia and Cardiovascular Complications , 2020, International journal of molecular sciences.
[31] L. Peng,et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. , 2020, Journal of the American Medical Directors Association.
[32] Tianjiao Tang,et al. Sarcopenia index based on serum creatinine and cystatin C is associated with 3-year mortality in hospitalized older patients , 2020, Scientific Reports.
[33] D. Sedding,et al. Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis , 2020, European heart journal.
[34] K. Choi,et al. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences , 2020, International journal of molecular sciences.
[35] P. Abete,et al. Sarcopenia and Heart Failure , 2020, Nutrients.
[36] K. Kohara,et al. Creatinine-to-cystatin C ratio as a marker of skeletal muscle mass in older adults: J-SHIPP study. , 2020, Clinical nutrition.
[37] Xiping Xu,et al. A U-shaped association between serum betaine and incident risk of first ischemic stroke in hypertensive patients. , 2019, Clinical nutrition.
[38] H. Liou,et al. Serum creatinine to cystatin C ratio predicts skeletal muscle mass and strength in patients with non-dialysis chronic kidney disease. , 2019, Clinical nutrition.
[39] C. Murray,et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The Lancet.
[40] C. Kennedy,et al. Validation of the sarcopenia index to assess muscle mass in the critically ill: A novel application of kidney function markers. , 2019, Clinical nutrition.
[41] Lin Wang,et al. Prevalence and risk factors of stroke in the elderly in Northern China: data from the National Stroke Screening Survey , 2019, Journal of Neurology.
[42] J. Viña,et al. Sarcopenia, frailty and their prevention by exercise. , 2019, Free radical biology & medicine.
[43] A. Rule,et al. Sarcopenia Index Is a Simple Objective Screening Tool for Malnutrition in the Critically Ill. , 2018, JPEN. Journal of parenteral and enteral nutrition.
[44] G. Shulman,et al. Mechanisms of Insulin Action and Insulin Resistance. , 2018, Physiological reviews.
[45] Xiping Xu,et al. Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients , 2018, Stroke.
[46] L. Ferrucci,et al. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty , 2018, Nature Reviews Cardiology.
[47] J. Batsis,et al. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies , 2018, Nature Reviews Endocrinology.
[48] M. Fukui,et al. Decreased the creatinine to cystatin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes. , 2018, Diabetes research and clinical practice.
[49] Hu Li,et al. Senescent cells: a therapeutic target for cardiovascular disease , 2018, The Journal of clinical investigation.
[50] Alan H. Daniels,et al. Diagnostic Criteria and Clinical Outcomes in Sarcopenia Research: A Literature Review , 2018, Journal of clinical medicine.
[51] C. Kennedy,et al. The sarcopenia index: A novel measure of muscle mass in lung transplant candidates , 2018, Clinical transplantation.
[52] R. Lindley. Stroke Prevention in the Very Elderly. , 2018, Stroke.
[53] V. Herasevich,et al. Evaluating Muscle Mass by Using Markers of Kidney Function: Development of the Sarcopenia Index , 2017, Critical care medicine.
[54] S. Bartels,et al. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey. , 2016, Clinical nutrition.
[55] Yoosoo Chang,et al. Relationship Between Low Relative Muscle Mass and Coronary Artery Calcification in Healthy Adults , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[56] Luigi Ferrucci,et al. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. , 2014, The lancet. Diabetes & endocrinology.
[57] M. Laakso,et al. Insulin resistance and hyperglycaemia in cardiovascular disease development , 2014, Nature Reviews Endocrinology.
[58] Yong-jun Choi,et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. , 2012, The journals of gerontology. Series A, Biological sciences and medical sciences.
[59] Misuzu Watanabe,et al. Association between sarcopenia and higher-level functional capacity in daily living in community-dwelling elderly subjects in Japan. , 2012, Archives of gerontology and geriatrics.
[60] Cuiying Wang,et al. Sarcopenia in the elderly: Basic and clinical issues , 2012, Geriatrics & gerontology international.
[61] M. Febbraio,et al. Muscles, exercise and obesity: skeletal muscle as a secretory organ , 2012, Nature Reviews Endocrinology.
[62] G. Paolisso,et al. Discovering pathways of sarcopenia in older adults: A role for insulin resistance on mitochondria dysfunction , 2011, The journal of nutrition, health & aging.
[63] J. Baeyens,et al. Sarcopenia: European consensus on definition and diagnosis , 2010, Age and ageing.
[64] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[65] A. Murray,et al. Kidney Function and Sarcopenia in the United States General Population: NHANES III , 2007, American Journal of Nephrology.
[66] M. Parmacek,et al. Myocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation. , 2007, Circulation research.
[67] V. Montori,et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies , 2006, The Lancet.
[68] H. Quan,et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. , 2004, Journal of clinical epidemiology.
[69] Suzanne G. Leveille,et al. Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin‐6 Serum Levels , 2002, Journal of the American Geriatrics Society.
[70] T. Rice,et al. Heart rate and blood pressure changes with endurance training: the HERITAGE Family Study. , 2001, Medicine and science in sports and exercise.